Expert consensus on COVID-19 vaccination for children with special medical conditions
10.19428/j.cnki.sjpm.2023.22819
- VernacularTitle:特殊健康状态儿童新型冠状病毒疫苗接种专家共识
- Author:
Xiangshi WANG
1
;
Tianxing FENG
2
;
Jingjing LI
1
;
Wenjie WANG
1
;
Yanling GE
1
;
Jinqiao SUN
1
;
Zhuoying HUANG
3
;
Xiang GUO
3
;
Zhi LI
3
;
Xiaodong SUN
3
;
Mei ZENG
1
Author Information
1. Children’ Hospital of Fudan University， Shanghai 201102， China
2. Shanghai Clinical Research and Trial Center， Shanghai 201203， China
3. Shanghai Municipal Center for Disease Control and Prevention， Shanghai 200051， China
- Publication Type:Journal Article
- Keywords:
special medical conditions;
children;
SARS-CoV-2 vaccine;
expert consensus
- From:
Shanghai Journal of Preventive Medicine
2023;35(8):840-854
- CountryChina
- Language:Chinese
-
Abstract:
Children with certain comorbidities and immunocompromising conditions are highly vulnerable to SARS-CoV-2 infection. Vaccination against SARS-CoV-2 is an important strategy to reduce death， critical illness and overall disease burden. With the evolving and increasing transmission of SARS-CoV-2， universal vaccination is essential to achieve this goal. Children with special medical conditions are considered as the priorities for SARS-CoV-2 vaccination. However， vaccine hesitancy towards the implementation of SARS-CoV-2 vaccination currently remains an urgent challenge. In order to promote the sustainable vaccination for those children in Shanghai as well as China， Shanghai municipal center for disease control and prevention， together with the national children’s medical center， children’s hospital of Fudan university and the expert group on immunization planning of the Shanghai preventive medicine association， organized a consensus expert working group to formulate the evidence-based recommendations and implementation suggestions for children with common chronic diseases， allergy history， diseases involving adverse events related to vaccination， and immunocompromising conditions， based on the published evidence of SARS-CoV-2 vaccination for populations and children with special medical conditions.
